Comparative protein structure network analysis on 3CLpro from SARS-CoV-1 and SARS-CoV-2

Proteins. 2021 Sep;89(9):1216-1225. doi: 10.1002/prot.26143. Epub 2021 May 22.

Abstract

The main protease Mpro , 3CLpro is an important target from coronaviruses. In spite of having 96% sequence identity among Mpros from SARS-CoV-1 and SARS-CoV-2; the inhibitors used to block the activity of SARS-CoV-1 Mpro so far, were found to have differential inhibitory effect on Mpro of SARS-CoV-2. The possible reason could be due to the difference of few amino acids among the peptidases. Since, overall 3-D crystallographic structure of Mpro from SARS-CoV-1 and SARS-CoV-2 is quite similar and mapping a subtle structural variation is seemingly impossible. Hence, we have attempted to study a structural comparison of SARS-CoV-1 and SARS-CoV-2 Mpro in apo and inhibitor bound states using protein structure network (PSN) based approach at contacts level. The comparative PSNs analysis of apo Mpros from SARS-CoV-1 and SARS-CoV-2 uncovers small but significant local changes occurring near the active site region and distributed throughout the structure. Additionally, we have shown how inhibitor binding perturbs the PSG and the communication pathways in Mpros . Moreover, we have also investigated the network connectivity on the quaternary structure of Mpro and identified critical residue pairs for complex formation using three centrality measurement parameters along with the modularity analysis. Taken together, these results on the comparative PSN provide an insight into conformational changes that may be used as an additional guidance towards specific drug development.

Keywords: Covid19; SARS coronavirus; main protease (Mpro, 3CLpro); protein structure graph; protein structure network.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoenzymes / antagonists & inhibitors
  • Apoenzymes / chemistry
  • Apoenzymes / metabolism
  • Binding Sites
  • Coronavirus 3C Proteases / antagonists & inhibitors
  • Coronavirus 3C Proteases / chemistry*
  • Coronavirus 3C Proteases / metabolism
  • Holoenzymes / chemistry
  • Holoenzymes / metabolism
  • Models, Molecular
  • Protease Inhibitors / pharmacology
  • Protein Multimerization / drug effects
  • Protein Structure, Quaternary / drug effects
  • SARS-CoV-2 / enzymology*
  • Severe acute respiratory syndrome-related coronavirus / enzymology*

Substances

  • Apoenzymes
  • Holoenzymes
  • Protease Inhibitors
  • Coronavirus 3C Proteases